Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Hemostatic dressing

a technology of hemostatic dressing and hemisphere, which is applied in the direction of drug compositions, peptide/protein ingredients, extracellular fluid disorder, etc., can solve the problems of reducing the interaction of the dressing components, reducing the effectiveness of the dressing in preventing hemorrhage, and not uncommon occurrence of excessive bleeding or fatal hemorrhage from an accessible site. , to achieve the effect of inhibiting the delamination of the layers

Inactive Publication Date: 2006-07-13
AMERICAN NAT RED CROSS
View PDF75 Cites 56 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention provides a hemostatic dressing that includes a layer of thrombin sandwiched between two layers of fibrinogen. The thrombin layer is non-coextensive with the fibrinogen layers, which means that the thrombin layer does not completely overlap with the fibrinogen layers. This design prevents delamination of the layers and allows for better inhibition of bleeding. The hemostatic dressing can be hydrated with liquids that are exogenous or endogenous to the wounded tissue. The invention also includes methods for preparing the hemostatic dressing and treating wounded tissue using the dressing."

Problems solved by technology

Unfortunately, the occurrence of excessive bleeding or fatal hemorrhage from an accessible site is not uncommon.
While this fibrinogen-thrombin dressing requires no premixing and is easy to use, its utility is limited by a requirement for storage at 4° C. and the necessity for prewetting with saline solution prior to application to the wound.
Such delamination can result in reduced interaction of the dressing components layers, with decreased effectiveness of the dressing in preventing hemorrhage.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0059] The example set forth below demonstrates that delamination of the dressings can be decreased by preparing a dressing in which the thrombin layer is not coextensive with the first and second fibrinogen layers. In this example, thrombin was dispensed onto the first fibrinogen layer in either of two configurations. In the conventional dressings, the thrombin fully covered the first fibrinogen layer (this configuration is referred to herein as “full” coverage). In the dressings of the invention, the thrombin was configured on top of the first fibrinogen layer as a single circle that was not coextensive with the first fibrinogen layer (this configuration is referred to herein as “circle” coverage).

[0060] To prepare the dressings, fibrinogen was formulated in a conventional manner: 35 mg / ml of total protein (TP) in Buffer D (100 mM NaCl, 1.1 mM CaCl2.H2O, 10 mM TrisHCl, 10 mM Sodium Citrate, 2% Sucrose, 2.8 mg / ml albumin, 0.52 mg / ml TWEEN-80, pH 7.2) containing albumin at 80 mg / g ...

example 2

[0080] The data set forth below in Table 2 demonstrate that delamination can be attributed to full coverage of the thrombin layer (or buffer) on the first fibrinogen layer. Dressings that were produced with thrombin applied such that the thrombin layer was not coextensive with the first fibrinogen layer generally passed the delamination appearance test (groups 9-11 and 13-16 in Table 2). Similarly, dressings that were produced with no middle layer, i.e., having only two fibrinogen layers, generally did not become delaminated, and the fibrinogen layers adhered tightly to each other.

[0081] In this example, fibrinogen was formulated as described above, and thrombin was formulated as described in Table 2. The fibrinogen layers (approx 1.2 mL) were applied using a programmable pipette, and the dressings were manufactured manually as described herein. The middle layer of the dressing (i.e., thrombin or fibrinogen) was applied either by spraying using an air brush or by pipetting. For eac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
pHaaaaaaaaaa
distanceaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a hemostatic dressing which comprises a plurality of layers that contain resorbable materials and / or coagulation proteins. In particular, the invention includes dressings in which a layer of thrombin is sandwiched between a first and second layer of fibrinogen and wherein the layer of thrombin is not coextensive with the first and / or second layer of fibrinogen. The hemostatic dressings are useful for the treatment of wounded tissue.

Description

FIELD OF THE INVENTION [0001] The present invention relates to a hemostatic dressing that comprises a plurality of layers that contain resorbable materials and / or coagulation proteins. The hemostatic dressing is useful for the treatment of wounded tissue. BACKGROUND OF THE INVENTION [0002] The control of hemorrhage (bleeding) is a critical step in first aid and field trauma care. Unfortunately, the occurrence of excessive bleeding or fatal hemorrhage from an accessible site is not uncommon. J. M. Rocko et al., J. Trauma 22:635 (1982). Mortality data from Vietnam indicates that 10% of combat deaths were due to uncontrolled extremity hemorrhage. SAS / STAT Users Guide, 4th ed. (Cary, N.C.: SAS Institute Inc; 1990). Up to one third of the deaths from exsanguination during the Vietnam War could have been prevented by the use of effective field hemorrhage control methods. SAS / STAT Users Guide, 4th ed. (Cary, N.C.: SAS Institute Inc; 1990). [0003] Although civilian trauma mortality statisti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61F15/00A61K38/48A61L15/32
CPCA61L15/64A61F2013/00463A61F13/00034A61F13/00063A61F2013/00106A61F2013/0091A61F13/00029A61F2013/00472A61F13/00991A61L15/225A61L15/32A61F2013/00927A61F2013/0054A61L2400/04A61K38/4833C08L89/00A61P7/04A61F13/01034A61F13/01029
Inventor MACPHEE, MARTINJBEALL, DAWSONFRIEDMAN, STANLEY
Owner AMERICAN NAT RED CROSS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com